Vanguard Group Inc Liquidia Corp Transaction History
Vanguard Group Inc
- $6.44 Trillion
- Q3 2025
A detailed history of Vanguard Group Inc transactions in Liquidia Corp stock. As of the latest transaction made, Vanguard Group Inc holds 3,961,217 shares of LQDA stock, worth $113 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,961,217
Previous 3,593,558
10.23%
Holding current value
$113 Million
Previous $44.8 Million
103.04%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding LQDA
# of Institutions
236Shares Held
53.9MCall Options Held
6.33MPut Options Held
7.87M-
Farallon Capital Management LLC San Francisco, CA8.57MShares$245 Million0.85% of portfolio
-
Black Rock Inc. New York, NY4.24MShares$121 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY2.83MShares$80.9 Million25.4% of portfolio
-
Goldman Sachs Group Inc New York, NY2.78MShares$79.5 Million0.01% of portfolio
-
Opaleye Management Inc. Boston, MA2.62MShares$74.7 Million10.0% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.84B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...